| Dr Efrain Andres Sanchez Caballero, MD | |
|
Mans De Sierra Taina, 114 Ave Los Pinos, Bayamon, PR 00956 | |
| (787) 671-4233 | |
| Not Available |
| Full Name | Dr Efrain Andres Sanchez Caballero |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Mans De Sierra Taina, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003456500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 23468 (Puerto Rico) | Primary |
| Entity Name | Casan Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891577805 PECOS PAC ID: 1254789910 Enrollment ID: O20231120001025 |
News Archive
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today reported preclinical data with ASG-5ME, an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. In models of human prostate and pancreatic cancer, ASG-5ME was found to have potent and long lasting antitumor activity. The findings were presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Efrain Andres Sanchez Caballero, MD Mans De Sierra Taina, 114 Ave Los Pinos, Bayamon, PR 00956 Ph: () - | Dr Efrain Andres Sanchez Caballero, MD Mans De Sierra Taina, 114 Ave Los Pinos, Bayamon, PR 00956 Ph: (787) 671-4233 |
News Archive
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.
Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading.
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today reported preclinical data with ASG-5ME, an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors. In models of human prostate and pancreatic cancer, ASG-5ME was found to have potent and long lasting antitumor activity. The findings were presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held in Washington, D.C.
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.
› Verified 1 days ago
Dr. Yadira Dominguez Vazquez, M.D. General Practice Medicare: Medicare Enrolled Practice Location: A14 Calle 1, Urb. Rexville, Bayamon, PR 00957 Phone: 787-239-7575 | |
Dr. Jean C De Los Santos Ramos, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Carretera # 2 Km 11.9, Bayamon, PR 00959 Phone: 787-620-8181 | |
Dr. Nicolle Spence, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 70 Calle Santa Cruz, Bayamon, PR 00961 Phone: 787-620-4747 | |
Dr. Jorge L Ortiz Melendez, General Practice Medicare: Medicare Enrolled Practice Location: V17 Calle 10, Alturas De Flamboyan, Bayamon, PR 00959 Phone: 787-795-2935 Fax: 787-784-0680 | |
Dr. Jesus R Sierra Diaz, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Calle Parque #32, Suite 3-a, Bayamon, PR 00959 Phone: 787-778-8637 Fax: 787-778-8637 | |
Dr. Martin Rosa, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 Vista Del Morro, Panorama Village, Bayamon, PR 00957 Phone: 787-797-6556 |